Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.

Phillip J MeaseDafna D GladmanJoseph F MerolaPeter NashStacy GrieveVictor Laliman-KharaDamon WillemsVanessa TaiebAdam R PrickettLaura C Coates

Published in: Rheumatology (Oxford, England) (2024)

Bimekizumab ranked favourably among b/tsDMARDs for efficacy on joint, skin and MDA outcomes, and showed comparable safety, suggesting it may be a beneficial treatment option for patients with PsA.

Keyphrases

systematic review
prostate cancer
meta analyses
breast cancer cells
type diabetes
randomized controlled trial
metabolic syndrome
skeletal muscle
combination therapy
cell death
case control
cell cycle arrest
glycemic control
smoking cessation
network analysis